Critical

NSTEMI / unstable angina - early management

ACS pathway · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Non-ST-elevation acute coronary syndrome managed by risk-stratified pathway: antiplatelet and anticoagulation, anti-ischaemic therapy and early invasive angiography for higher-risk patients (e.g. GRACE), with urgent intervention for ongoing ischaemia or instability.

Assessment

Investigations

  • Serial ECGs and high-sensitivity troponin
  • GRACE risk score; identify ongoing ischaemia/instability
  • Bloods, echo as needed

Management

  • Aspirin 300 mg; add a second antiplatelet per pathway/local protocol
  • Anticoagulation (e.g. fondaparinux) unless going to immediate angiography
  • Anti-ischaemic therapy: nitrates, beta-blocker (if no contraindication)
  • Early invasive angiography - within 24 h if high risk (GRACE >140/ongoing ischaemia), within 72 h otherwise
  • Immediate angiography for refractory ischaemia, instability or dynamic changes (treat as STEMI-equivalent)
  • Oxygen only if SpO2 <94%; analgesia
  • CCU/monitored bed; secondary prevention

Drugs & doses

Aspirin 300 mg + 2nd antiplatelet
Fondaparinux (anticoagulation)
Nitrate / beta-blocker
Early angiography (risk-based)

Disposition

CCU/cardiology.

Risk-stratify NSTEMI with GRACE - high-risk or ongoing ischaemia goes to angiography within 24 hours, and refractory ischaemia is a STEMI-equivalent.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.